Welcome: Guest | Site Use Options | Register | Login |

Xalud Therapeutics Inc

Xalud Therapeutics Inc

Profile last edited on: 7/24/2019
30 Hill Street
San Francisco, CA 94110
  (650) 380-1926
Business Identifier: Novel Therapies for Neuro-Inflammation
Public Profile:
Xalud Therapeutics, Inc develops therapies developed at the University of Colorado for the treatment of neuro-inflammatory diseases and inflammatory joint disorders including osteoarthritis and rheumatoid arthritis. The company's primary product is XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. The drug treats pain through threating the inflammation that is responsible for the persistent, amplified pain signaling rather than attempting to directly block pain signaling. The firm's therapies have been succesfully tested on dogs and have recieved numerous acolades.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options


Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920